Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
FLIP-FRAPing One’s Way Toward Polyglutamine Pathogenesis
28 June 2002. At least nine neurodegenerative disorders-Huntington’s disease being perhaps the best known-are caused by the reiteration of glutamine-coding CAG trinucleotides in the genome. In huntingtin, ataxins, and other proteins, these repeats result in expanded polyglutamine tracts (PolyQ), which form nuclear inclusions. Whether aggregated or soluble monomeric polyQ proteins are the key pathogenic species is hotly debated (see related news item). One line of thought follows from the observation that polyQ protein inclusions sequester other, essential proteins, such as transcription factors (see related news item).

A report in the current PNAS early edition supports the idea that polyQ protein aggregation mediates cellular damage. Yaohui Chai and colleagues at Henry Paulson’s lab, University of Iowa, used exquisite, real-live imaging techniques to measure the diffusion of both mutant ataxin-3, which causes spinocerebellar ataxia type-3 or Machado-Joseph disease, and the transcription factor CBP (cAMP response element binding protein-binding protein), which has been identified in these nuclear inclusions. The authors expressed both proteins as green fluorescent protein (GFP) chimeras, which they photobleached in distinct cellular locations with a highly focused laser beam. The time it took unbleached chimeras to diffuse into this bleached zone after the laser was stopped (fluorescence recovery after photobleaching, or FRAP), and the rate at which fluorescence was lost during photobleaching (FLIP), revealed remarkable differences in protein mobility.

For example, normal ataxin-3, (28 glutamines), diffuses readily in the cytoplasm, and almost as fast in the nucleus. In contrast, mutant protein (84 glutamines) diffuses just as quickly in the cytoplasm as does wild type, but slows down markedly in the nucleus, and stays put in nuclear inclusions. CBP chimeras are freely diffusible when co-expressed with wild-type ataxin-3 but, in the presence of mutant ataxin-3, become trapped in nuclear inclusions.

The data support the idea that polyQ-expanded proteins sequester others. But the results also suggest that not all polyQ proteins are created equal. While CBP was sequestered by mutant ataxin-3 and mutant huntingtin, mutant ataxin-1 inclusions failed to retain the transcription factor, which freely diffused in and out of them.-Tom Fagan.

Reference:
Chai Y, Shao J, Miller VM, Williams A, Paulson HL. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. PNAS 2002 June 25 Early EditionAbstract

 
Comments on News and Primary Papers
  Primary Papers: Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.

Comment by:  George Perry (Disclosure)
Submitted 8 July 2002  |  Permalink Posted 8 July 2002
  I recommend this paper
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad